Strasbourg, 27/10/2005 (Agence Europe) - With the adoption on Wednesday 26 October in Strasbourg by 338 votes in favour, 272 against and 35 abstentions, of a resolution on the patentability of biotechnological inventions, the European Parliament has rekindled a highly complex debate which blends legal and technical aspects with ethical and economic considerations. Initially, and independently of the capacity of any person to voice opposition, a very slim majority (318 for, 299 against and 24...